Vellum Health, Inc.

Vellum Health, Inc. , based in the US, provides a mobile IV delivery platform that enhances patient care outside traditional hospital environments through convenient, high-quality intravenous therapies. Founded in 2023 and headquartered in Austin, Texas, Vellum Health, Inc. specializes in mobile IV healthcare services.

The company has completed 2 deals to date. It was founded by individuals with a history in healthcare innovation, although specific details about them are not available. The firm has not indicated any significant changes in its business strategy or operations since its inception. Vellum Health specializes in providing a mobile IV delivery platform that focuses on offering high-quality intravenous care outside of traditional hospital settings.

Their core product offerings include 24/7 mobile IV enablement, treatment, and clinical education, aimed at enhancing patient convenience while delivering care in post-acute settings such as homes and skilled nursing facilities. Their services allow healthcare providers to administer IV therapy quickly, often within 4-6 hours, utilizing trained professionals equipped with advanced navigation and documentation technology. Vellum Health serves a diverse clientele, including skilled nursing facilities, home infusion pharmacies, payers, and acute care providers, across various geographical markets in the United States. The company’s technology integrates seamlessly with electronic medical records (EMR) systems, empowering providers to identify and act on new care opportunities efficiently.

Vellum Health generates revenue through a business-to-business model that focuses on partnerships with healthcare providers and payers. Their revenue structure involves direct contracts with skilled nursing facilities, home infusion pharmacies, and acute care centers, which utilize Vellum's IV administration services to enhance patient care while reducing costs associated with hospital care. The company's offerings, which include on-demand IV infusions, peripheral IV insertion, and clinical training programs, are designed to improve operational efficiency and patient outcomes. Vellum Health’s services are billed per administration or through service agreements that could include subscription-like elements for ongoing training and support.

Specific pricing plans and revenue figures associated with these offerings are not publicly disclosed but are integral to the company's business model as they seek to optimize value-based care for their clients. Vellum Health, Inc. raised an undisclosed amount of Seed funding from individual investors. The company will utilize this funding for research and development.

Future growth strategies include the design and launch of new products aimed at improving IV delivery capabilities and expanding their services to additional geographic regions, although specific markets and timelines for these expansions have not been detailed.